| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 566.36B | 528.66B | 520.93B | 521.89B | 479.94B | 442.77B |
| Gross Profit | 25.02B | 21.63B | 18.44B | 13.27B | 14.33B | 17.55B |
| EBITDA | 19.75B | 19.67B | 12.20B | 11.76B | 10.33B | 13.73B |
| Net Income | 7.91B | 7.18B | 6.96B | 6.51B | 5.99B | 5.64B |
Balance Sheet | ||||||
| Total Assets | 259.92B | 218.78B | 193.13B | 168.15B | 167.33B | 161.03B |
| Cash, Cash Equivalents and Short-Term Investments | 65.43B | 43.13B | 36.96B | 42.80B | 36.65B | 38.85B |
| Total Debt | 101.40B | 79.25B | 62.16B | 55.07B | 52.78B | 53.00B |
| Total Liabilities | 162.37B | 124.60B | 105.33B | 91.40B | 85.38B | 83.22B |
| Stockholders Equity | 84.11B | 81.31B | 77.95B | 67.42B | 73.52B | 69.80B |
Cash Flow | ||||||
| Free Cash Flow | -9.11B | -11.50B | -4.08B | 4.12B | 5.33B | 6.16B |
| Operating Cash Flow | -5.38B | -6.91B | 2.51B | 10.93B | 10.64B | 9.03B |
| Investing Cash Flow | -13.39B | 3.21B | -12.30B | -8.23B | -7.72B | -3.23B |
| Financing Cash Flow | 26.44B | 3.30B | 5.73B | 1.93B | -9.75B | 1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$227.31B | 7.66 | 19.96% | 3.32% | 1.76% | 2.25% | |
72 Outperform | HK$53.42B | 18.26 | 16.75% | 2.28% | -10.48% | -0.04% | |
67 Neutral | HK$105.62B | 26.80 | 16.36% | ― | 38.74% | 173.81% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | HK$163.53B | 18.51 | 8.84% | 3.23% | 4.60% | 6.74% | |
54 Neutral | HK$2.25B | 31.74 | -1.53% | ― | 14.33% | 37.50% |